The Role of Pharmaceuticals in Public Health

Access to Essential Medicines as a Key Determinant to Universal Health Coverage

Health Reform, Universal Health Coverage, And Access To Medicines

Pharmaceutical Public Health: The BUSPH Vision

Thursday, September 15, 2016

9 a.m.–5:30 p.m.
Instructional Building
72 East Concord Street
Hiebert Lounge
Full Agenda
#BUSPH40 #BUSPHSymposia

Symposium Summary

What is the role of pharmaceuticals in a prevention and public health agenda? The symposium will explore this question by engaging public and private sector actors.

Speakers

Olusoji O. Adeyi

Director, Health, Nutrition, and Population Global Practice, World Bank Group, Washington, DC
Presentation

Margaret Ewen

Coordinator, Global Projects (Pricing), Health Action International, Netherlands
Presentation

Erin Hasselberg

Director, Pharmaceuticals Certificate Program and Adjunct Clinical Assistant Professor, Global Health, Boston University School of Public Health
Presentation with Richard Laing

Richard Laing

Professor, Global Health, Boston University School of Public Health
Presentation with Erin Hasselberg

Ye Lu

Professor and Director of Health Economics, School of Public Health, Fudan University, Shanghai, China
Presentation

Peter Maybarduk

Director, Access to Medicines & Knowledge Economy Group at Public Citizen, Washington, DC

Stefan J. Oschmann

President, IFPMA; Chairman and CEO of Merck KGaA, Darmstadt, Germany

Jonathan D. Quick

President and Chief Executive Officer, Management Sciences for Health, Boston, MA

Vin Sharma

Senior Director of Business Planning and Program/Alliance Management at Alnylam Pharmaceuticals, Boston, MA

Pius Tih

Director, Cameroon Baptist Convention Health Services, Cameroon
Presentation

Veronika J. Wirtz

Associate Professor, Global Health, Boston University School of Public Health
Presentation